Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paige Lewis

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
MMWR. Morbidity and Mortality Weekly Report|September 5, 2014
Notes from the field: reports of expired live attenuated influenza vaccine being administered--United States, 2007-2014Penina Haber, Christopher P Schembri, Paige Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013Pedro L Moro, Jorge Arana, Maria Cano, et al.
Vaccine|November 1, 2015
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015Pedro L Moro, Scott Winiecki, Paige Lewis, et al.
American Journal of Obstetrics and Gynecology|January 1, 2014
Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant womenPedro L Moro, Oidda I Museru, Manette Niu, et al.
Drug Safety|December 19, 2016
Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016Pedro Moro, Jane Baumblatt, Paige Lewis, et al.
Vaccine|November 13, 2016
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015Penina Haber, Jorge Arana, Tamara Pilishvili, et al.
Vaccine|February 12, 2019
Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018Penina Haber, Pedro L Moro, Carmen Ng, et al.
Vaccine|December 18, 2017
Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012Beth F Hibbs, Elaine Miller, Jing Shi, et al.
Vaccine|March 27, 2016
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015Penina Haber, Pedro L Moro, Paige Lewis, et al.
Vaccine|May 19, 2015
Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013Beth F Hibbs, Pedro L Moro, Paige Lewis, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
MMWR. Morbidity and Mortality Weekly Report|September 5, 2014
Notes from the field: reports of expired live attenuated influenza vaccine being administered--United States, 2007-2014Penina Haber, Christopher P Schembri, Paige Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013Pedro L Moro, Jorge Arana, Maria Cano, et al.
Vaccine|November 1, 2015
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015Pedro L Moro, Scott Winiecki, Paige Lewis, et al.
American Journal of Obstetrics and Gynecology|January 1, 2014
Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant womenPedro L Moro, Oidda I Museru, Manette Niu, et al.
Drug Safety|December 19, 2016
Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016Pedro Moro, Jane Baumblatt, Paige Lewis, et al.
Vaccine|November 13, 2016
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015Penina Haber, Jorge Arana, Tamara Pilishvili, et al.
Vaccine|February 12, 2019
Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018Penina Haber, Pedro L Moro, Carmen Ng, et al.
Vaccine|December 18, 2017
Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012Beth F Hibbs, Elaine Miller, Jing Shi, et al.
Vaccine|March 27, 2016
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015Penina Haber, Pedro L Moro, Paige Lewis, et al.
Vaccine|May 19, 2015
Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013Beth F Hibbs, Pedro L Moro, Paige Lewis, et al.
Pageof 6